Viral respiratory diseases (ILT, aMPV infections, IB): are they ever under control?
1. The use of vaccines is the main approach to control of the economically important poultry viral respiratory diseases infectious laryngotracheitis (ILT), avian metapneumovirus (aMPV) infections and infectious bronchitis (IB). This paper appraises the current methods of vaccine control in the light of the nature of each virus and epidemiological factors associated with each disease. 2. Infectious laryngotracheitis virus (ILTV) exists as a single type with a wide range of disease severity. It is a serious disease in certain regions of the world. Recent work has distinguished molecular differences between vaccine and field strains and vaccine virus can be a cause of disease. Vaccines have remained unaltered for many years but new ones are being developed to counter vaccine side effects and reversion and reactivation of latent virus. 3. Avian metapneumoviruses, the cause of turkey rhinotracheitis and respiratory disease in chickens exists as 4 subtypes, A, B, C and D. A and B are widespread and vaccines work well provided that accurate doses are given. Newer vaccine developments are designed to eliminate reversion and possibly counter the appearance of newer field strains which may break through established vaccine coverage. 4. IB presents the biggest problem of the three. Being an unstable RNA virus, part of the viral genome that codes for the S1 spike gene can undergo mutation and recombination so that important antigenic variants can appear irregularly which may evade existing vaccine protection. While conventional vaccines work well against homologous types, new strategies are needed to counter this instability. Molecular approaches involving tailoring viruses to suit field challenges are in progress. However, the simple use of two genetically different vaccines to protect against a wide range of heterologous types is now a widespread practice that is very effective. 5. None of the three diseases described can claim to be satisfactorily controlled and it remains to be seen whether the newer generations of vaccines will be more efficacious and cost effective. The importance of constant surveillance is emphasised and the testing of novel vaccines cannot be achieved without the use of vaccine-challenge experiments in poultry.
Jones
Richard C
RC
School of Veterinary Science, University of Liverpool, Neston, South Wirral, England, UK. jonesrc@liv.ac.uk
D000818:Animals; D001352:Herpesvirus 1, Gallid / Q000276:immunology; D001351:Infectious bronchitis virus / Q000276:immunology; D029121:Metapneumovirus / Q000276:immunology; D011200:Poultry; D011201:Poultry Diseases / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000821:virology*; D012140:Respiratory Tract Diseases / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D014765:Viral Vaccines / Q000276:immunology* / Q000592:standards; D014777:Virus Diseases / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology
D014765:Viral Vaccines
Avian Dis. 2006 Mar;50(1):28-34
16617977
J Gen Virol. 2005 Mar;86(Pt 3):719-725
15722532
Vaccine. 2006 Oct 30;24(42-43):6476-82
16901592
Avian Pathol. 1990 Jan;19(1):181-5
18679926
Avian Pathol. 1988;17(4):841-50
18766745
Avian Pathol. 2005 Aug;34(4):297-302
16147565
Biosci Biotechnol Biochem. 2009 Jul;73(7):1500-4
19584555
Avian Dis. 2007 Dec;51(4):900-4
18251400
Avian Pathol. 1997;26(2):257-76
18483906
Virus Res. 1998 Nov;58(1-2):45-52
9879761
Avian Dis. 2008 Mar;52(1):111-7
18459306
Emerg Infect Dis. 2009 Jul;15(7):1091-4
19624927
Onderstepoort J Vet Res. 1989 Jun;56(2):87-98
2748138
Vet Rec. 1971 Sep 11;89(11):317-8
5098189
J Gen Virol. 1992 Sep;73 ( Pt 9):2415-20
1328497
J Gen Virol. 2004 Nov;85(Pt 11):3219-3227
15483235
J Vet Sci. 2009 Sep;10(3):219-23
19687622
Avian Dis. 2008 Mar;52(1):59-63
18459297
Avian Pathol. 2008 Jun;37(3):287-92
18568655
Avian Pathol. 2008 Oct;37(5):487-93
18798022
Avian Pathol. 1996 Dec;25(4):639-48
18645888
J Gen Virol. 1994 Nov;75 ( Pt 11):2873-80
7964599
Biochem Biophys Res Commun. 2008 Dec 5;377(1):221-5
18840402
Avian Pathol. 2008 Jun;37(3):343-51
18568663
Avian Dis. 2006 Mar;50(1):50-4
16617981
J Gen Virol. 2000 Nov;81(Pt 11):2723-2733
11038385
Vet Rec. 1987 Jun 27;120(26):617-8
2820108
Avian Dis. 2008 Jun;52(2):278-83
18646457
Vet Microbiol. 2007 Sep 20;124(1-2):134-9
17462834
Arch Virol. 2009;154(7):1117-24
19543689
Avian Pathol. 2001 Jun;30(3):233-42
19184905
Avian Dis. 2009 Jun;53(2):184-9
19630222
Avian Pathol. 1999 Oct;28(5):477-85
26911602
J Virol. 2001 Dec;75(24):12359-69
11711626
Avian Pathol. 1995 Sep;24(3):373-91
18645796
Avian Pathol. 1991 Mar;20(1):45-55
18679998
Virus Genes. 2009 Jun;38(3):383-91
19242786
J Gen Virol. 2005 Jun;86(Pt 6):1597-1607
15914837
Vet Rec. 1995 Apr 15;136(15):392-3
7604520
Virus Res. 2007 Sep;128(1-2):18-25
17485129
Avian Pathol. 1997;26(4):677-706
18483939
Vet Microbiol. 1996 Dec;53(3-4):239-52
9008335
Avian Pathol. 2009 Apr;38(2):149-53
19322714
Avian Dis. 2007 Dec;51(4):974-8
18251411
Res Vet Sci. 1989 Mar;46(2):274-6
2539638
Arch Virol. 1991;121(1-4):213-8
1662039
Vaccine. 2007 Jul 26;25(30):5558-62
17416443
Avian Pathol. 1992;21(2):287-94
18670940
Vet Rec. 1988 Apr 9;122(15):370-1
3132782
Avian Pathol. 2008 Jun;37(3):247-57
18568650
Avian Pathol. 2006 Apr;35(2):77-85
16595297
J Gen Virol. 2009 Nov;90(Pt 11):2679-2685
19625463
J Virol. 2009 Jan;83(2):908-17
18971277
J Gen Virol. 2008 Feb;89(Pt 2):525-533
18198384
Avian Dis. 2003 Apr-Jun;47(2):261-71
12887186
Avian Pathol. 2006 Aug;35(4):286-92
16854641
Avian Pathol. 2009 Feb;38(1):47-53
19156579
Virus Res. 2002 Feb 26;83(1-2):207-12
11864753
Avian Pathol. 2008 Feb;37(1):83-8
18202954
Vaccine. 2003 Mar 28;21(13-14):1355-62
12615430
Virus Res. 2007 Dec;130(1-2):121-8
17629993
Vet Rec. 2005 May 14;156(20):646-7
15894731
Vaccine. 2006 Nov 17;24(47-48):6830-8
16860445
Virus Genes. 2006 Feb;32(1):97-103
16525740